# Aegon Ltd. share price today (Aegon Ltd., AEG)

> Aegon Ltd.'s earnings have grown faster than its share price. Earnings per share grew +58.8% in a year while the price moved +8.5%. AEG · Financials · Insurance - Diversified · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/aeg

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $8.21 (+8.5% in a year)
- P/BV: 1.2× (lower than 56% of the last 4.8 years)
- Revenue (Jun 2026): $5.7 B (−8.2% on a year ago)
- Profit (Jun 2026): $608 M (+0.5% on a year ago)
- Net margin: 10.6% (+0.9 points on a year ago)
- ROE: 11%, FY25
- ROA: 0.10%, latest

The main question: yearly earnings per share moved +58.8% while the share price moved +8.5%. ## What is the Aegon Ltd. share price today? Aegon Ltd.'s share price was $8.21 at the close on 3 November 2026. It has been moving sideways for 3 weeks. That is 1.2% below its average price over the last 200 trading days. In the last 52 weeks it traded between $7 and $10, and at that close it sat 52% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 7 weeks running. Over the last 10 years the share price moved +124% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 18 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Aegon Ltd. pay? Aegon Ltd. paid $0.80 per share over the last four reported quarters. The most recent declaration was $0.21 for Jun 2026. At today's price of $8.21 that is a yield of 9.74%, based on dividends already paid, not a forecast. ## Which stock lists is Aegon Ltd. on? Aegon Ltd. is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Aegon Ltd. profitable? Aegon Ltd. earned $608 M of net profit in the Jun 2026 quarter, +0.5% on the same quarter a year earlier. Full-year FY25 profit was $980 M. Over 4 years profit has grown −12.9% a year on average. That is 10.6% of the quarter's revenue. The same quarter a year earlier lost $65.0 M. 5 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $980 M (+45.0% on the year before). ## How much revenue does Aegon Ltd. make, and is it growing? Aegon Ltd. reported $5.7 B of income in the Jun 2026 quarter, −8.2% on the same quarter a year earlier. Over 4 years it has grown −28.4% a year on average. The last full year, FY25, came in at $12.2 B. FY25 revenue was $12.2 B, −5.1% on the year before. Recent pace: the last four quarters grew −5.7% on average, against −28.4% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −9.4%, against −47.4% a year over the last 8 quarters (accelerating). ## How much does Aegon Ltd. keep from what it earns? Aegon Ltd.'s net margin was 10.6% in the Jun 2026 quarter, 0.9 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Over the last four quarters it has moved +11.6 percentage points. Across 5 years it has been between −3.8% and 8.0%. The latest quarter is above every full year in that period. Across 5 years it has been between −3.8% and 8.0%, and FY25's 8.0% is the highest of them. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead. ## How many of Aegon Ltd.'s loans have gone bad? Aegon Ltd. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Aegon Ltd.'s loan book growing? Aegon Ltd.'s revenue was $12.2 B in FY25, −5.1% on the year before, so the loan book is not growing. The latest quarter was −8.2% on a year earlier. The net margin on that income is 10.6%, +0.9 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Aegon Ltd.'s P/BV ratio, and how does it compare with its own history? Aegon Ltd.'s P/BV is 1.2×, in the middle of its own history: higher than 44% of past readings. Its usual P/BV (the middle reading) is 1.3×, over 4.8 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is low: this lender earns about 11% a year on its equity. A lender that earns less on its net worth is valued lower for each dollar of it, and that gap usually closes only if returns improve. Keep one thing in mind: the net margin is the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks. Why the multiple is where it is: over the past year book value grew while the price moved +8.5%. Price and book value moved together, so the multiple stayed in its range. Where the price move came from: over 5 years the price moved +10.5% a year; about −12.8% a year came from book-value growth and about +23.3 percentage points from the multiple (the market paying more). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the book value trend underneath matters more than the multiple. ## Is the Aegon Ltd. business getting better or worse? Aegon Ltd.'s business is giving mixed signals. Revenue and EPS growth are shrinking while ROE is still rising at 25.9%, so growth and returns point different ways. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Aegon Ltd. earn on its equity and assets? Aegon Ltd. earned a return on equity of 10% in FY25. Its lowest yearly reading on file was −5% in FY22. On its assets, every $100 earned about $0.10, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is. Why ROE moved: profit grew −12.9% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does Aegon Ltd. have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Aegon Ltd. shareholding pattern? 0.2% of Aegon Ltd.'s tradable shares are in short positions, which are bets that the price will fall, so very few traders are betting against this stock. At normal trading volumes, closing those positions would take about 0.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Aegon Ltd. from balance-sheet trouble? For Aegon Ltd., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Aegon Ltd. rank in its industry? 55.5 out of 100, rank 6 of 10 in Insurance - Diversified, with 56% of the evidence available. Aegon Ltd. scores 55.5 out of 100 against the 10 companies it is compared with in Insurance - Diversified, ranking 6. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 19.5 + 15.8 + 16.3 + 3.9 = 55.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Aegon Ltd. compared with? Aegon Ltd. ranks 6 of 10 Insurance - Diversified companies on the 4-Factor Sector Score, with 55.5 out of 100. 1. [Arch Capital Group Ltd.](https://www.sectoralpha.in/us/stocks/acgl) ACGL · turning · Most evidence points up · 80% evidence 71.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.3/35 · Income 0.4% · Profit 25.9% · 81% evidence Capital efficiency 18.6/25 · ROA 3.6% · ROE 17.3% · GNPA n/a · 68% evidence Valuation 14.9/20 · P/BV 1.41× · P/BV÷ROE 0.08 · 70% evidence Relative strength 17.0/20 · Lead over its industry 7.9% · Lead over S&P 500 6.3% · 1 year 20.3% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.3 + 18.6 + 14.9 + 17 = 71.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Exzeo Group, Inc.](https://www.sectoralpha.in/us/stocks/xzo) XZO · turning · Most evidence points up · 74% evidence 67.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.0/35 · Income 25% · Profit 52.7% · 81% evidence Capital efficiency 19.9/25 · ROA 19% · ROE 30.9% · GNPA n/a · 68% evidence Valuation 8.1/20 · P/BV 5.32× · P/BV÷ROE 0.17 · 70% evidence Relative strength 11.7/20 · Lead over its industry 3.2% · Lead over S&P 500 1.2% · 1 year -8.2% · 70% evidence · 8 of 12 weeks ahead Exact sum: 28 + 19.9 + 8.1 + 11.7 = 67.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Pelagos Insurance Capital Limited](https://www.sectoralpha.in/us/stocks/plgo) PLGO · turning · Most evidence points up · 69% evidence 67.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Income -3.6% · Profit n/a · 52% evidence Capital efficiency 15.4/25 · ROA 2.3% · ROE 18.6% · GNPA n/a · 68% evidence Valuation 16.2/20 · P/BV 0.94× · P/BV÷ROE 0.05 · 70% evidence Relative strength 16.7/20 · Lead over its industry 15.5% · Lead over S&P 500 14.3% · 1 year 38.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 18.8 + 15.4 + 16.2 + 16.7 = 67.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. Berkshire Hathaway Inc. BRK-A · breaking out · Evidence leans up · 80% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Income 3.9% · Profit 36.3% · 81% evidence Capital efficiency 11.5/25 · ROA 2.7% · ROE 5.6% · GNPA n/a · 68% evidence Valuation 5.7/20 · P/BV 1.44× · P/BV÷ROE 0.26 · 70% evidence Relative strength 17.5/20 · Lead over its industry 8% · Lead over S&P 500 6.5% · 1 year 11.8% · 100% evidence · 4 of 12 weeks ahead Exact sum: 24.3 + 11.5 + 5.7 + 17.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [The Hartford Insurance Group, Inc.](https://www.sectoralpha.in/us/stocks/hig) HIG · basing · Evidence leans up · 80% evidence 57.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.9/35 · Income 7% · Profit 34.7% · 81% evidence Capital efficiency 17.5/25 · ROA 3% · ROE 17% · GNPA n/a · 68% evidence Valuation 12.6/20 · P/BV 1.85× · P/BV÷ROE 0.11 · 70% evidence Relative strength 3.9/20 · Lead over its industry -3.7% · Lead over S&P 500 -5.2% · 1 year 4.3% · 100% evidence · 1 of 12 weeks ahead Exact sum: 23.9 + 17.5 + 12.6 + 3.9 = 57.9 · What this means: Earnings are strong; relative strength in its sector is -3.7% and the one-year return is 4.3%. 6. Aegon Ltd. this page AEG · quiet · Too little evidence to rank firmly · 56% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Income n/a · Profit n/a · 15% evidence Capital efficiency 15.8/25 · ROA 2.3% · ROE 76.9% · GNPA n/a · 68% evidence Valuation 16.3/20 · P/BV 1.25× · P/BV÷ROE 0.02 · 70% evidence Relative strength 3.9/20 · Lead over its industry -2.9% · Lead over S&P 500 -4% · 1 year 8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 19.5 + 15.8 + 16.3 + 3.9 = 55.5 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [American International Group, Inc.](https://www.sectoralpha.in/us/stocks/aig) AIG · turning · Evidence leans down · 80% evidence 42.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.3/35 · Income -2.4% · Profit -7.3% · 81% evidence Capital efficiency 10.7/25 · ROA 1.9% · ROE 7.5% · GNPA n/a · 68% evidence Valuation 8.6/20 · P/BV 0.97× · P/BV÷ROE 0.13 · 70% evidence Relative strength 11.1/20 · Lead over its industry 0.3% · Lead over S&P 500 -1.3% · 1 year 4.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 12.3 + 10.7 + 8.6 + 11.1 = 42.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [International General Insurance Holdings Ltd.](https://www.sectoralpha.in/us/stocks/igic) IGIC · quiet · Evidence leans down · 80% evidence 39.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.9/35 · Income -1.9% · Profit -13.6% · 81% evidence Capital efficiency 15.6/25 · ROA 2.9% · ROE 12.7% · GNPA n/a · 68% evidence Valuation 11.5/20 · P/BV 1.64× · P/BV÷ROE 0.13 · 70% evidence Relative strength 2.1/20 · Lead over its industry -4.5% · Lead over S&P 500 -5.9% · 1 year 14.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 9.9 + 15.6 + 11.5 + 2.1 = 39.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Sun Life Financial Inc.](https://www.sectoralpha.in/us/stocks/slf) SLF · turning · Evidence leans down · 80% evidence 36.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.6/35 · Income 4.1% · Profit 2.2% · 81% evidence Capital efficiency 7.5/25 · ROA 0.5% · ROE 7.4% · GNPA n/a · 68% evidence Valuation 3.8/20 · P/BV 2.31× · P/BV÷ROE 0.31 · 70% evidence Relative strength 13.5/20 · Lead over its industry 9% · Lead over S&P 500 7.8% · 1 year 37.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.6 + 7.5 + 3.8 + 13.5 = 36.4 · What this means: Relative strength against the index is 7.8%, and revenue and profit growth are weak. 10. [Brookfield Wealth Solutions Ltd.](https://www.sectoralpha.in/us/stocks/bnt) BNT · basing · Most evidence points down · 68% evidence 19.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 3.8/35 · Income -17.5% · Profit -84.2% · 81% evidence Capital efficiency 4.3/25 · ROA -0.4% · ROE -13.8% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV 0.8× · P/BV÷ROE n/a · 10% evidence Relative strength 2.0/20 · Lead over its industry -9.5% · Lead over S&P 500 -11% · 1 year -11.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 3.8 + 4.3 + 9.8 + 2 = 19.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Insurance - Diversified](https://www.sectoralpha.in/us/sectors/insurance-diversified), all 10 compared on one page. ## Which companies are close to Aegon Ltd. in size? Aegon Ltd. is the 7th largest of 11 Insurance - Diversified companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: The Hartford Insurance Group, Inc., Arch Capital Group and Brookfield Wealth Solutions. Just below it: Pelagos Insurance Capital, Exzeo Group, Inc. and International General Insurance Holdings. ### Insurance - Diversified companies close in size

1. [The Hartford Insurance Group, Inc.](https://www.sectoralpha.in/us/stocks/hig) $36.1 billion
2. [Arch Capital Group Ltd.](https://www.sectoralpha.in/us/stocks/acgl) $35 billion
3. [Brookfield Wealth Solutions Ltd.](https://www.sectoralpha.in/us/stocks/bnt) $14.5 billion
4. Aegon Ltd. $12.4 billion
5. [Pelagos Insurance Capital Limited](https://www.sectoralpha.in/us/stocks/plgo) $2.2 billion
6. [Exzeo Group, Inc.](https://www.sectoralpha.in/us/stocks/xzo) $1.6 billion
7. [International General Insurance Holdings Ltd.](https://www.sectoralpha.in/us/stocks/igic) $1 billion

[All 11 Insurance - Diversified companies, largest first](https://www.sectoralpha.in/us/sectors/insurance-diversified#all-companies)

### Companies close in size in other industries

1. [Antero Resources Corporation](https://www.sectoralpha.in/us/stocks/ar) $12.5 billion · Oil & Gas Exploration & Production
2. [Evercore Inc.](https://www.sectoralpha.in/us/stocks/evr) $12.5 billion · Capital Markets
3. Aegon Ltd. $12.4 billion
4. [Huntington Ingalls Industries, Inc.](https://www.sectoralpha.in/us/stocks/hii) $12.4 billion · Aerospace & Defense
5. [DT Midstream, Inc.](https://www.sectoralpha.in/us/stocks/dtm) $12.3 billion · Oil & Gas Midstream

## What else do people ask about Aegon Ltd.? ### What were Aegon Ltd. Ltd.'s latest quarterly results? Aegon Ltd. reported total income of $5.7 B and net profit of $608 M for the Jun 2026 quarter. Income fell 8.2% and profit rose 0.5% compared with a year earlier. Earnings per share were $0.39. The net margin was 10.6%, 0.9 percentage points higher than a year earlier (as of 3 November 2026). ### What is Aegon Ltd. Ltd.'s market cap? Aegon Ltd.'s market capitalisation is $12.4 B at a stock price of $8.21. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Aegon Ltd. Ltd. performing? Aegon Ltd.'s share price has been moving sideways for 3 weeks. In its latest quarter, income fell 8.2% and profit rose 0.5% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 7 weeks running (as of 3 November 2026). ### Will Aegon Ltd. Ltd.'s stock price go up? This page does not forecast Aegon Ltd.'s stock price. What it shows instead: the stock price is $8.21, and it has been moving sideways for 3 weeks. Its P/BV of 1.2× is higher than 44% of its own last 5 years (as of 3 November 2026). ### Where is Aegon Ltd. Ltd. in its business cycle? Aegon Ltd.'s FY25 net margin was 8.0%, against a 5-year range of −3.8% to 8.0%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 10.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Aegon Ltd. Ltd. story? The main question: yearly earnings per share moved +58.8% while the share price moved +8.5%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Aegon Ltd. Ltd. a stock worth studying right now? What the numbers show: Aegon Ltd.'s earnings have grown faster than its share price. Earnings per share grew +58.8% in a year while the price moved +8.5%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.